These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10892573)

  • 1. Breast cancer: challenges and opportunities.
    Sledge GW; Miller K
    Semin Oncol; 1999 Dec; 26(6 Suppl 18):1-5. PubMed ID: 10892573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy for locally advanced breast cancer.
    Specht J; Gralow JR
    Semin Radiat Oncol; 2009 Oct; 19(4):222-8. PubMed ID: 19732686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of novel targeted therapies into the systemic treatment of breast cancer--a review.
    Tsakonas G; Kosmas C
    J BUON; 2007; 12(3):319-27. PubMed ID: 17918284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-based therapies in breast cancer: current status and future perspectives.
    Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
    Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in adjuvant therapy for breast cancer.
    Slamon DJ; Romond EH; Perez EA;
    Clin Adv Hematol Oncol; 2006 Mar; 4(3 Suppl 7):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10. PubMed ID: 16736568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current trends in pharmacotherapy of breast cancer].
    Boér K
    Orv Hetil; 2002 Apr; 143(14):725-30. PubMed ID: 11975393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for breast cancer.
    Hennessy BT; Pusztai L
    Minerva Ginecol; 2005 Jun; 57(3):305-26. PubMed ID: 16166938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
    Awada A
    Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.
    Witters LM; Witkoski A; Planas-Silva MD; Berger M; Viallet J; Lipton A
    Oncol Rep; 2007 Feb; 17(2):465-9. PubMed ID: 17203189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in management of small-cell lung cancer.
    Chua YJ; Steer C; Yip D
    Cancer Treat Rev; 2004 Oct; 30(6):521-43. PubMed ID: 15325033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
    Wagner AD; Moehler M
    Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer.
    Johnston SR
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1061s-1068s. PubMed ID: 16467125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapies in breast cancer.
    Tripathy D
    Breast J; 2005; 11 Suppl 1():S30-5. PubMed ID: 15725114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 and response to paclitaxel in node-positive breast cancer.
    Mehta R
    N Engl J Med; 2008 Jan; 358(2):197-8; author reply 198. PubMed ID: 18193531
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted cancer therapies.
    Blay JY; Le Cesne A; Alberti L; Ray-Coquart I
    Bull Cancer; 2005 Feb; 92(2):E13-8. PubMed ID: 15749638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodiagnostics and targeted therapies - a rational approach for individualizing medical anticancer therapy in breast cancer.
    Jørgensen JT; Nielsen KV; Ejlertsen B
    Oncologist; 2007 Apr; 12(4):397-405. PubMed ID: 17470682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer in the 21st century: neu opportunities and neu challenges.
    Schnitt SJ
    Mod Pathol; 2001 Mar; 14(3):213-8. PubMed ID: 11266529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel systemic therapies for breast cancer.
    Lo S; Johnston SR
    Surg Oncol; 2003 Dec; 12(4):277-87. PubMed ID: 14998568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.